Align Tech (ALGN) Stock Forecast & Price Target

Compare

3,361 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ALGN Analyst Ratings

Moderate Buy

8 Buy

4 Hold

1 Sell

Based on 13 analysts giving stock ratings to

Align

Tech

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ALGN Stock 12 Month Forecast

Average Price Target

$198.70

▲(4.57% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Align Tech in the last 3 months. The average price target is $198.70 with a high forecast of $220.00 and a low forecast of $169.00. The average price target represents a 4.57% change from the last price of $190.02.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"126":"$126","221":"$221","149.75":"$149.8","173.5":"$173.5","197.25":"$197.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":220,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$220.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":198.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$198.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":169,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$169.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[126,149.75,173.5,197.25,221],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,163.63,167.96615384615384,172.3023076923077,176.63846153846154,180.9746153846154,185.31076923076924,189.6469230769231,193.9830769230769,198.31923076923078,202.6553846153846,206.99153846153848,211.3276923076923,215.66384615384615,{"y":220,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,163.63,166.3276923076923,169.0253846153846,171.72307692307692,174.42076923076922,177.11846153846153,179.81615384615384,182.51384615384615,185.21153846153845,187.90923076923076,190.60692307692307,193.30461538461537,196.00230769230768,{"y":198.7,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,163.63,164.0430769230769,164.45615384615385,164.86923076923077,165.28230769230768,165.69538461538463,166.10846153846154,166.52153846153846,166.93461538461537,167.3476923076923,167.76076923076923,168.17384615384614,168.58692307692309,{"y":169,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":219.11,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.03,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.08,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.74,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.51,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":194.28,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":136.52,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.16,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.52,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.88,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":146.72,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.15,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.63,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$220.00

Average Price Target$198.70

Lowest Price Target$169.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Steven Valiquette

Mizuho Securities

$215

Buy

13.15%

Upside

Reiterated

02/10/26

Mizuho Securities Sticks to Their Buy Rating for Align Tech (ALGN)

Sidharth Sahoo

HSBC

$150→$200

Buy

5.25%

Upside

Upgraded

02/09/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Elizabeth Anderson CFA

Evercore ISI

$200

Buy

5.25%

Upside

Reiterated

02/09/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Align Tech (NASDAQ: ALGN), Vertex Pharmaceuticals (NASDAQ: VRTX) and Pfizer (NYSE: PFE)

Erin Wright

Morgan Stanley

$154→$169

Hold

-11.06%

Downside

Reiterated

02/05/26

Analysts Conflicted on These Healthcare Names: Align Tech (NASDAQ: ALGN) and Boston Scientific (NYSE: BSX)

Jeff Johnson

Robert W. Baird

$205→$218

Buy

14.72%

Upside

Reiterated

02/05/26

Align Technology price target raised to $218 from $205 at BairdAlign Technology price target raised to $218 from $205 at Baird

Jonathan Block

Stifel Nicolaus

$200→$210

Buy

10.51%

Upside

Reiterated

02/05/26

Align Technology price target raised to $210 from $200 at StifelAlign Technology price target raised to $210 from $200 at Stifel

Glen Santangelo

Barclays

$170

Hold

-10.54%

Downside

Reiterated

02/05/26

Align Tech (ALGN) Gets a Hold from Barclays

Kevin Caliendo

UBS

$175→$185

Hold

-2.64%

Downside

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: Boston Scientific (NYSE: BSX), Arcellx Inc (NASDAQ: ACLX) and Align Tech (NASDAQ: ALGN)

Michael Ryskin

Bank of America Securities

―

Sell

―

Reiterated

02/05/26

Analysts Conflicted on These Healthcare Names: Align Tech (NASDAQ: ALGN) and Eli Lilly & Co (NYSE: LLY)

Vik Chopra

Wells Fargo

$181→$200

Buy

5.25%

Upside

Reiterated

02/05/26

Wells Fargo Keeps Their Buy Rating on Align Tech (ALGN)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

02/05/26

Align Technology: Resilient Core Markets, DSO-Driven Growth, and Attractive Valuation Support Buy Rating

David Saxon

Needham

―

Hold

―

Reiterated

02/05/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (NASDAQ: ACLX), Align Tech (NASDAQ: ALGN) and M3 (Other OTC: MTHRF)

Jason Bednar

Piper Sandler

$200→$220

Buy

15.78%

Upside

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (NASDAQ: HTFL), Theravance Biopharma (NASDAQ: TBPH) and Align Tech (NASDAQ: ALGN)

Michael Cherny

Leerink Partners

$188→$172

Buy

-9.48%

Downside

Reiterated

10/14/25

Leerink Partners Sticks to Its Buy Rating for Align Tech (ALGN)

Michael Sarcone

Jefferies

$215→$140

Hold

-26.32%

Downside

Downgraded

10/10/25

Align Technology downgraded to Hold from Buy at JefferiesAlign Technology downgraded to Hold from Buy at Jefferies

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Steven Valiquette

Mizuho Securities

$215

Buy

13.15%

Upside

Reiterated

02/10/26

Mizuho Securities Sticks to Their Buy Rating for Align Tech (ALGN)

Sidharth Sahoo

HSBC

$150→$200

Buy

5.25%

Upside

Upgraded

02/09/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Elizabeth Anderson CFA

Evercore ISI

$200

Buy

5.25%

Upside

Reiterated

02/09/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Align Tech (NASDAQ: ALGN), Vertex Pharmaceuticals (NASDAQ: VRTX) and Pfizer (NYSE: PFE)

Erin Wright

Morgan Stanley

$154→$169

Hold

-11.06%

Downside

Reiterated

02/05/26

Analysts Conflicted on These Healthcare Names: Align Tech (NASDAQ: ALGN) and Boston Scientific (NYSE: BSX)

Jeff Johnson

Robert W. Baird

$205→$218

Buy

14.72%

Upside

Reiterated

02/05/26

Align Technology price target raised to $218 from $205 at BairdAlign Technology price target raised to $218 from $205 at Baird

Jonathan Block

Stifel Nicolaus

$200→$210

Buy

10.51%

Upside

Reiterated

02/05/26

Align Technology price target raised to $210 from $200 at StifelAlign Technology price target raised to $210 from $200 at Stifel

Glen Santangelo

Barclays

$170

Hold

-10.54%

Downside

Reiterated

02/05/26

Align Tech (ALGN) Gets a Hold from Barclays

Kevin Caliendo

UBS

$175→$185

Hold

-2.64%

Downside

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: Boston Scientific (NYSE: BSX), Arcellx Inc (NASDAQ: ACLX) and Align Tech (NASDAQ: ALGN)

Michael Ryskin

Bank of America Securities

―

Sell

―

Reiterated

02/05/26

Analysts Conflicted on These Healthcare Names: Align Tech (NASDAQ: ALGN) and Eli Lilly & Co (NYSE: LLY)

Vik Chopra

Wells Fargo

$181→$200

Buy

5.25%

Upside

Reiterated

02/05/26

Wells Fargo Keeps Their Buy Rating on Align Tech (ALGN)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

02/05/26

Align Technology: Resilient Core Markets, DSO-Driven Growth, and Attractive Valuation Support Buy Rating

David Saxon

Needham

―

Hold

―

Reiterated

02/05/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (NASDAQ: ACLX), Align Tech (NASDAQ: ALGN) and M3 (Other OTC: MTHRF)

Jason Bednar

Piper Sandler

$200→$220

Buy

15.78%

Upside

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (NASDAQ: HTFL), Theravance Biopharma (NASDAQ: TBPH) and Align Tech (NASDAQ: ALGN)

Michael Cherny

Leerink Partners

$188→$172

Buy

-9.48%

Downside

Reiterated

10/14/25

Leerink Partners Sticks to Its Buy Rating for Align Tech (ALGN)

Michael Sarcone

Jefferies

$215→$140

Hold

-26.32%

Downside

Downgraded

10/10/25

Align Technology downgraded to Hold from Buy at JefferiesAlign Technology downgraded to Hold from Buy at Jefferies

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Align Tech

3 Months

xxx

Success Rate

14/21 ratings generated profit

Average Return

+12.06%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +12.06% per trade.

1 Year

Steven ValiquetteMizuho Securities

Success Rate

14/21 ratings generated profit

Average Return

+13.01%

reiterated a buy rating 13 days ago

Copying Steven Valiquette's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +13.01% per trade.

2 Years

xxx

Success Rate

13/21 ratings generated profit

Average Return

+14.97%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 61.90% of your transactions generating a profit, with an average return of +14.97% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALGN Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ALGN has received 51 Buy Ratings, 38 Hold Ratings, and 2 Sell Ratings. ALGN average Analyst price target in the past 3 months is 198.70.

Each month's total comprises the sum of three months' worth of ratings.

ALGN Financial Forecast

ALGN Earnings Forecast

Next quarter’s earnings estimate for ALGN is $2.31 with a range of $2.23 to $2.53. The previous quarter’s EPS was $3.29. ALGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.

ALGN Sales Forecast

Next quarter’s sales forecast for ALGN is $1.02B with a range of $1.02B to $1.03B. The previous quarter’s sales results were $1.05B. ALGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.

ALGN Stock Forecast FAQ

What is ALGN’s average 12-month price target, according to analysts?

Based on analyst ratings, Align Tech’s 12-month average price target is 198.70.

What is ALGN’s upside potential, based on the analysts’ average price target?

Align Tech has 4.57% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ALGN a Buy, Sell or Hold?

Align Tech has a consensus rating of Moderate Buy which is based on 8 buy ratings, 4 hold ratings and 1 sell ratings.

What is Align Tech’s price target?

The average price target for Align Tech is 198.70. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $220.00 ,the lowest forecast is $169.00. The average price target represents 4.57% Increase from the current price of $190.02.

What do analysts say about Align Tech?

Align Tech’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of ALGN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Align Tech (ALGN) Stock Forecast & Price Target

ALGN Analyst Ratings

ALGN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Align Tech

ALGN Analyst Recommendation Trends

ALGN Financial Forecast

ALGN Earnings Forecast

ALGN Sales Forecast

ALGN Stock Forecast FAQ

Detailed List of Analyst Forecasts